MWA
BNR

Marshall Wace Asia’s Burning Rock Biotech BNR Stock Holding History

Marshall Wace Asia’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,952
Closed -$913K – 151
2020
Q4 		$913K Sell
3,952
-2,465
-38% -$662K 0.02% 134
2020
Q3 		$1.61M Buy
+6,417
New +$1.52M 0.04% 101

Other funds holding BNR

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marshall Wace Asia's BNR Position: Q1 2021 in Review

Marshall Wace Asia sold out of Burning Rock Biotech (BNR) in Q1 2021, closing a stake of 3,952 shares — an estimated $913K sold.

Marshall Wace Asia first reported a position in BNR in Q3 2020 and held it in 2 quarters. The position peaked at $1.61M in Q3 2020. 54 funds tracked by Wall St. Rank hold BNR as of Q1 2021.

  • Marshall Wace Asia reported no remaining Burning Rock Biotech position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace Asia sold 3,952 Burning Rock Biotech shares in Q1 2021, an estimated $913K.
  • Marshall Wace Asia first reported a position in Burning Rock Biotech in Q3 2020 and held it in 2 quarters.
  • Marshall Wace Asia's Burning Rock Biotech position peaked at $1.61M in Q3 2020.
  • 54 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2021.

Based on Marshall Wace Asia's 13F filing for Q1 2021, filed 17 May 2021.